Matthew Brams - Feb 25, 2022 Form 4 Insider Report for Cingulate Inc. (CING)

Role
EVP and Chief Medical Officer
Signature
/s/ Shane J. Schaffer, Attorney-in-Fact
Stock symbol
CING
Transactions as of
Feb 25, 2022
Transactions value $
$0
Form type
4
Date filed
3/1/2022, 05:00 PM
Previous filing
Dec 7, 2021
Next filing
Mar 8, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CING Stock Option (right to Buy) Award $0 +12.5K $0.00 12.5K Feb 25, 2022 Common Stock 12.5K $1.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as follows: 25% on the one-year anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date.